Abstract:Intermetallic phases represent a group of materials of unique properties. Many of those materials have found practical application, whereas others are still intensively examined. There are ten stable intermetallic phases in Al-Zr system, among which few are prospective materials to work at elevated temperature, nuclear reactors, etc. On top of that, researches are focused on obtaining amorphous phases, nanoparticles and zirconium-based pressure pipes covered with aluminum. As a result, better understanding of … Show more
The main objective of this paper is to investigate the effect of Zr and its synergistic effect together with the addition of an inoculant (Ti) and a modifier (Sr) in terms of structural analysis and mechanical characteristics of AlSi7Mg0.3Cu0.5 alloy. In accordance with the objectives of the paper, in the experimental part, eight material variants were cast by the investment casting method. The presence of Zr in the experimental alloys was manifested by the crystallization of phases with different chemical compositions mainly (AlSi)3(TiZr) and (AlSi)2(TiZr). The graded addition of Ti in the alloys resulted in a higher number of nucleation grains of Zr-rich phases, and alloys with a combination of Zr and Sr were characterized by the formation of (AlSi)2(TiZr) phases. Various types of precipitates based on Zr (Al3(ZrTi)) and Cu (Al2Cu) were observed in the substructure of the alloys. The addition of Zr and its synergistic effect with Ti and Sr led to an increase in the conventional yield strength, hardness and partly tensile strength with reduced elongation of the experimental alloys.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.